Table 1. Clinical characteristics of the patients with breast cancer.
Samples | HER2 positive (IHC + + + and + + with gene amplification by FISH) |
HER2 negative (IHC−, +, and ++ without gene amplification by FISH) |
Normal control | p | |
---|---|---|---|---|---|
Sample No. | 36 | 60 | 79 | ||
Age(year) | 52.3(31~82) | 53.1(31~78) | 46.4(24~86) | >0.05 | |
ER positive | n=11 (5 for test set) as Luminal B subtype | n=42 (22 for test set) as Luminal A subtype | \ | ||
ER negative | n=25 (10 for test set) as HER2-enriched subtype | n=18 (8 for test set) as Basal-like subtype | \ | ||
TNM classification stage | I | 6 | 25 | \ | |
IIA | 19 | 20 | \ | ||
IIIA | 1 | 1 | \ | ||
IIIB | 10 | 14 | \ |
HER2, human epidermal growth factor receptor 2;
ER, estrogen receptor;
IHC, immunohistochemistry;
FISH, fluorescence in situ hybridization.